Page 31 - Health News

New Zealand could face another Covid-19 wave before year-end: Report

New Zealand could be hit by another wave of coronavirus before the end of the year, a Covid modeler warned

Ajay Singh-owned SpiceHealth's auditor resigns, says busy with other work

On August 1 this year, Bubber Jindal and Company tendered its resignation as statutory auditor of SpiceHealth

Redefining 'death': Organ transplants, donation may get a legal nudge

The government is considering changing the definition of "death" in the law on organ transplants

How artificial intelligence is making diagnosis faster and more accurate

It addresses the shortage of radiologists and pathologists and frees up doctors to deal with complex cases

Most job vacancies recorded during third Covid wave were in health sector

Besides health, trade and IT/BPO sectors saw vacancies increasing during the pandemic's Omicron phase

Pharma supply start-up Saveo Healthcare raises $4.5mn in venture round

Company founded by 4 IIT graduates will use money to expand its presence and for improving technology

Torrent Pharma acquires cosmetic derma player Curatio for Rs 2,000 cr

First major acquisition by Aman Mehta after taking charge at Torrent Pharma in August

Stay committed to patients in India and Fortis Healthcare, says IHH

Taking legal advice on next steps to pursue open offer for 26% stake in Fortis

Spike in fever cases: Dengue, malaria, swine flu take over from Covid-19

Some cities like Delhi and Mumbai are also witnessing cases of leptospirosis and gastroenteritis fevers

Govt forms 5-member committee to review pharma marketing practices

It will recommend 'legally enforceable mechanisms', is expected to give a report in 90 days

Happilo: Farmer's son and a nutty biz selling good health in small packs

Vikas Nahar's enterprise does Rs 40 cr a month on average, selling exotic and local nuts processed at 16,000 sq ft of processing space that he now plans to scale up by another 100,000 sq ft

India's Covid vaccination programme stunning: Roche's Hoffmann, Duschmale

'They (the next 125 years) look more challenging than the past 125 years. The world has changed. We have to make quicker decisions'

Peerless group poised for growth, targets Rs 1,000 crore turnover

PGFI's revenues for the year ended March 31, 2022, had stood at around Rs 498 crore while profit for the year was at 102.76 crore. But pre-Covid, turnover was in the region of Rs 535 crore

The SSI Mantra: India's own surgical robot boasts cheaper price tag

SSI Mantra has already been used for 22 complex procedures at Delhi hospital

Pashu Aadhaar: How will it help control lumpy skin disease in cattle

What is Pashu Aadhaar and how to apply for it? Here's all you need to know

Lupin gets nod for arthritis drug 'Rymti' from Canadian health authority

Drug maker Lupin on Tuesday said its biosimilar product Rymti, indicated for the treatment of arthritis, has received approval from the Canadian health authority. The company's product is the biosimilar of reference drug Enbrel (Etanercept). The product is indicated for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis , plaque psoriasis and paediatric plaque psoriasis. "The approval for Rymti in Canada is a key milestone in our endeavours to improve access to medicines," Lupin Biotech President Cyrus Karkaria said in a statement. It underscores the scientific success of the company's biosimilar programmes and commitment to advancing healthcare through innovation, he added.

Tata Consumer enters health supplements biz with 'GoFit' range for women

Tata GoFit is available in two pack sizes of 500 grams and one kg, with 18 grams of protein per serving of 25 grams in two flavours--rich chocolate and cafe mocha

Serum Institute may give India its first adult tuberculosis vaccine

Will be critical to the success of India's drive to eliminate TB by 2025

What is Tomato Flu? Causes, symptoms, prevention, and treatment

Tomato Flu cases have surged in India, more than three months after its inception. Read this detailed article to understand Tomato Flu, its causes, symptoms, diagnosis and treatment

Pricing regulator closely watching prices of diabetes drug going off patent

Regulator looking to cap prices of Sitagliptin, Linagliptin and combinations